Targeting HIF2α Translation with Tempol in VHL-Deficient Clear Cell Renal Cell Carcinoma
Carole Sourbier(Center for Drug Evaluation and Research), W. Marston Linehan(National Cancer Institute)
Cited by 21
Related Papers
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma
|Nature Communications|2021|167
Metabolic Reprogramming for Producing Energy and Reducing Power in Fumarate Hydratase Null Cells from Hereditary Leiomyomatosis Renal Cell Carcinoma
|PLoS ONE|2013|110
Targeting loss of the Hippo signaling pathway in <i>NF2</i>-deficient papillary kidney cancers
|Oncotarget|2018|57